Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder.
Paschen-Wolff M, Greenfield SF, Kathryn McHugh R, Burlew K, Pavlicova M, Choo TH, Barbosa-Leiker C, Ruglass LM, Mennenga S, Rotrosen J, Nunes EV, Campbell ANC. Paschen-Wolff M, et al. Among authors: ruglass lm. Am J Addict. 2023 Nov;32(6):584-592. doi: 10.1111/ajad.13463. Epub 2023 Aug 15. Am J Addict. 2023. PMID: 37583120 Clinical Trial.
Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study.
Ruglass LM, Miele GM, Hien DA, Campbell AN, Hu MC, Caldeira N, Jiang H, Litt L, Killeen T, Hatch-Maillette M, Najavits L, Brown C, Robinson JA, Brigham GS, Nunes EV. Ruglass LM, et al. Subst Use Misuse. 2012 May;47(6):695-707. doi: 10.3109/10826084.2012.659789. Epub 2012 Apr 4. Subst Use Misuse. 2012. PMID: 22475068 Free PMC article.
Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study.
McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. McClure EA, et al. Among authors: ruglass lm. J Subst Abuse Treat. 2015 Jun;53:39-46. doi: 10.1016/j.jsat.2014.12.007. Epub 2014 Dec 30. J Subst Abuse Treat. 2015. PMID: 25595301 Free PMC article.
Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.
Hien DA, Campbell AN, Ruglass LM, Saavedra L, Mathews AG, Kiriakos G, Morgan-Lopez A. Hien DA, et al. Among authors: ruglass lm. J Subst Abuse Treat. 2015 Sep;56:23-33. doi: 10.1016/j.jsat.2015.04.001. Epub 2015 Apr 7. J Subst Abuse Treat. 2015. PMID: 25907849 Free PMC article.
Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone.
Ruglass LM, Scodes J, Pavlicova M, Campbell ANC, Fitzpatrick S, Barbosa-Leiker C, Burlew K, Greenfield SF, Rotrosen J, Nunes EV Jr. Ruglass LM, et al. Drug Alcohol Depend. 2019 Dec 1;205:107649. doi: 10.1016/j.drugalcdep.2019.107649. Epub 2019 Oct 21. Drug Alcohol Depend. 2019. PMID: 31704382 Free PMC article. Clinical Trial.
60 results